1. Katzung BG. Farmacologia generale e clinica, VII edizione italiana a cura del Prof. P. Preziosi, Ed Piccin, Ormoni delle gonadi ed inibitori, Cap.40 pag. 658- 687.
2. Katzung BG. Farmacologia generale e clinica, VII edizione italiana a cura del Prof. P. Preziosi, Ed Piccin, Ormoni ipotalamici ed ipofisari, Cap.37, pag. 604- 621.
3. G.Aicardi FISIOLOGA: dalle molecole ai sistemi integrati, Ed. EdiSES, Il sistema riproduttivo, Cap. 26, pag. 393-417
4. Thomas L. Lemke FOYE’S Principi di Chimica Farmaceutica, V edizione italiana sulla sesta americana a cura di F.Dall’Acqua, S.Caffieri, Ed. Piccin, La salute della donna, Cap. 46, 1423-1426
5. Mendelsohn ME, Karas RH. Rapid progress for non-nuclear estrogen receptor signaling. J Clin Invest. 2010, 120, 2277–2279.
6. Kumar R.; Zakharov M. N.; Khan S. H.; Miki R.; Jang H.; Toraldo G.; Singh R.; Bhasin S.; Jasuja R.; The Dynamic Structure of the Estrogen Receptor; Journal of Amino Acids 2011, 1-7.
7. Joan S. Lewis, V. Craig Jordan, Estrogen receptor molulators (SERMs): Mechanism of anticarcinogenesis and drug resistence, Mutation Research 2005, 591, 247-263
8. Heldring N, Pike A, Andersson S, Matthews J, Cheng G, Hartman J, Tujague M, Ström A, Treuter E, Warner M, Gustafsson J-Å. Estrogen Receptors: How Do They Signal and What Are Their Targets, Physiol Rev 2007, 87, 905–931.
9. Minutolo F, Macchia M, Katzenellenbogen BS, Katzenellenbogen JA. Estrogen Receptor β Ligands: Recent Advances and Biomedical Applications, Medicinal Research Reviews 2011, 31, 364-442.
10. P. Hadhi, The evolution of selective estrogen receptor modulators in osteoporosis therapy, Climacteric, 2012, 15, 513-523.
11. Lewis J-S., Jordan V-C., Selective estrogen receptor modulators (SERMs): Mechanisms of anticarcinogenesis and drug resistance, Mutation Research, 2005, 591,247–263
129 12. Wright K.D, Cavailles V., Fuqua S. A., Jordan V. C., Katzenellenbogen J. A., Korach K. S., Maggi A., Muramatsu M, Parker M. G., Gustafsson J-Å International Union of Pharmacology LXIV Estrogen Receptor, Pharmacological Reviews, 2006, 58, 773–781.
13. Zhao L , Yao J, Mao Z, Chen S, Yan Wang Y, Diaz Brinton R. 17β-Estradiol regulates insulin-degrading enzyme expression via an ERβ/PI3-K pathway in hippocampus: Relevance to Alzheimer’s prevention, Neurobiology of Aging, 2011, 32, 1949–1963
14. De Angelis M, Stossi F, Carlson K.E., Katzenellenbogen B.S., Katzenellenbogen J.A. Indazole estrogens: Highly selective ligands for the estrogen receptor β, Journal of Medicinal Chemistry, 2005, 48, 1132–1144.
15. Bertini S., Andrea D.C., Granchi C., Bargagli B., Tuccinardi T., Martinelli A., Macchia M., Gunther J-R., Carlson K-E., Katzenellenbogen J-A., Minutolo F., Selective and potent agonist for estrogen receptor beta derived from molecular refinements of salicylaldoximes, European Journal of Medicinal Chemistry, 2011, 46, 2453-2462.
16. Minutolo F., BelliniR., Bertini S., Carboni I., Lapucci A., Pistolesi L., Prota G., Rapposelli S., Solati S., Tuccinardi T., Martinelli A., Stossi F., Carlson K-E., Katzenellenbogen B-S,. Katzenellenbogen J-A., Macchia M., Monoaryl- Substituted Salicylaldoximes as Ligands for Estrogen Receptor β, Journal of Medicinal Chemistry, 2008, 51, 1344-1351.
17. Minutolo F, Bertini S, Granchi C,Marchitiello T, Prota G, Rapposelli S, Tuccinardi T, Martinelli A, Gunther J-R, Carlson K-E, Katzenellenbogen JA, Macchia M, Structural evolutions of salicylaldoximes as selective agonists for estrogen receptor β, Journal of Medicinal Chemistry, 2009, 52, 858–867.
18. Asim M., El-Salfiti, Qian Y., Choueir C., Salari S., Cheng J., Shadnia H., Bal M., Pratt M-A-C., Carison K-E., Katzenellenbogen J-A., Wright J-S., Durst T., Deconstructing estradiol: Removal of B-ring generates compounds which are potent and subtype-selective estrogen receptor agonists, Bioorganic & Medicinal Chemistry Letters, 2009, 19, 1250-1253
19. Meyers M-J., Sun J., Carlson K-E., Marriner G-A., Katzenellenbogen B-S., Katzenellenbogen J-A., Estrogen receotor-β potency-selective-ligands:
130 structural-activity relationship studies of diarylproprionitriles and their acetylene and polar analogues, Journal of Medicinal Chemistry, 2001, 44, 4230-4251. 20. Waibel M., Kieser K-J., Carlson K-E., Stossi F., Katzenellenbogen B-S.,
Katzenellenbogen J-A., Phenethyl pyridines with non polar internal substituents as selective ligands for estrogen receptor beta, European Journal of Medicinal Chemistry, 2009, 44, 3560-3570.
21. Waibel M., De Angelis M., Stossi F., Kieser K-J., Carlson K-E., Katzenellenbogen B-S., Katzenellenbogen J-A., Bibenzyl- and stilbene-core compounds with non-polar linker atom substituents as selective ligands for estrogen receptor beta, European Journal of Medicinal Chemistry, 2009, 44, 3412-3424.
22. The discovery of tetrahydrofluorenones ad a new class of estrogen receptor β- subtype selective ligands, Bioorganic & Medicinal Chemistry Letters, 2006, 16, 3489-3494.
23. Synthesis and structure-activity relationship of 3-arylbenzoxazines as selective estrogen receptor β agonist, Bioorganic & Medicinal Chemistry Letters, 2004, 14, 2327-2330.
24. Ohta K., Chiba Y., Ogawa T., Endo Y., Promising core for nuclear receptor ligands: desing and synthesis of novel estrogen receptor ligands based on diphenylamine skeleton, Bioorganic & Medicinal Chemistry Letters, 2008, 18, 5050-5053.
25. Sulfonamide as selective oestrogen receptor β agonists, Bioorganic & Medicinal Chemistry Letters, 2011, 21, 5680-5683.
26. Miyaura N., Suzuki A., Palladium-catalyzed cross-coupling reactions of organoboron cwcdccompounds, Chemical Reviews, 1995, 95, 2457-2483
27. McOmie JFW, Watts ML, West DE. Demethylation of aryl methyl ethers by boron tribromide, Tetrahedron 1968, 24, 2289-2292.
28. Tiziano Tuccinardi, Simone Bertini, Adriano Martinelli, Filippo Minutolo, Gabriella Ortore, Giorgio Placanica, Giovanni Prota, Simona Rapposelli, Kathryn E. Carlson, John A. Katzenellenbogen, Marco Macchia, Synthesis of Anthranylaldoxime Derivatives as Estrogen Receptor Ligands and Computational Prediction of Binding Modes, J. Med. Chem. 2006, 49, 5001- 5012.
131 29. Baroni M., Cruciani G., Scabiola S., Perruccio F., Mason J.S., A Common Reference Framework for Analyzing/Comparing Proteins and Ligands. Fingerprints for Ligands And Proteins (FLAP): Theory and Application, Journal of Chemical Information and Modeling 2007, 47, 279-294.
30. Friesner R-A., Banks J-L., Murphy R-B., Halgren T-A., Klicic J-J., Mainz D-T., Repasky M- P., Knoll E-H., Shelley M., Perry J-K., Shaw D-E., Francis P., Shenkin P-S., Glide: A new approach for rapid, accurate docking and scoring.1. Method abd assessment of docking accuracy, 2004, 47, 1739-1749.
31. Marck McGann, FRED Pose Prediction and Virtual Screening Accuracy, Journal of Chemical information and Modeling, 2011, 51, 578-596.
32. Hao-Yang Liu, Irwin D. Kuntz, Xiaoqin Zou, Pairwise GB/SA Scoring Function for Structure-based Drug Design, Journal of Physical Chemistry, 2004, 108, 5453-5462.
33. Di Qiu, Shenkin P-S.,. Hollinger F-P., Still W-C., The GB/SA continuum model for solvation. A fast analytical method for the calculation of approximate born radii, Journal of Physical Chemistry, 1997, 101, 3005-3014.
34. Pfizer prod inc, Chesworth R., Gegnas L-D., Benzimidazole compounds and their use as estrogen agonists/antagonists, WO 2004000817, 2003.
35. Hiroi H, Tsutsumi O, Momoeda M, Takai Y, Osuga Y, Taketani Y, Differential interactions of bisphenol A and 17beta-estradiol with estrogen receptor alpha (ERalpha) and ERbeta, Endocrine Journal, 1999, 46, 773-778.
36. Hsiang-Ru Lin, Martin K. Safo, Donald J. Abraham, Identification of a series of tetrahydroisoquinoline derivatives as potential therapeutic agents for breast cancer, Bioorganic & Medicinal Chemistry Letters, 2007, 17, 2581-2589.
37. AstraZeneca AB, Barlaam B., Dantzman C., Selective estrogen receptor β ligands, US 7256201, 2007
38. Biotropics Malaysia Berhard, Bl Köpcke, Ernst Roemer, Jens Bitzer, Joachim Hans,Joerg Gruenwald, Matthias Gehling, Philipp Wabnitz, Adnan Tengku, Shahrir Tengku,Torsten Grothe, Aurones as estrogen receptor modulators and their use in sex hormone dependent diseases, WO 2010110647 A1, 2010.